Literature DB >> 18056274

In vitro activities of voriconazole, itraconazole, and terbinafine alone or in combination against Pythium insidiosum isolates from Brazil.

Juliana S Argenta1, Janio M Santurio, Sydney H Alves, Daniela I B Pereira, Ayrton S Cavalheiro, Andréia Spanamberg, Laerte Ferreiro.   

Abstract

We evaluated the in vitro activities of voriconazole, itraconazole, and terbinafine against 30 clinical isolates of Pythium insidiosum using a checkerboard macrodilution method. The combined activity of terbinafine plus itraconazole or plus voriconazole was synergic against 17% of the strains. Antagonism was not observed.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18056274      PMCID： PMC2224725          DOI： 10.1128/AAC.01075-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  14 in total

Review 1.  Antifungal agents of use in animal health--chemical, biochemical and pharmacological aspects.

Authors:  H Vanden Bossche; M Engelen; F Rochette
Journal:  J Vet Pharmacol Ther       Date:  2003-02       Impact factor: 1.786

Review 2.  Combinations of antifungal agents in therapy--what value are they?

Authors:  Manuel Cuenca-Estrella
Journal:  J Antimicrob Chemother       Date:  2004-09-16       Impact factor: 5.790

3.  In vitro interaction of terbinafine with itraconazole against clinical isolates of Scedosporium prolificans.

Authors:  J Meletiadis; J W Mouton; J L Rodriguez-Tudela; J F Meis; P E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

Review 4.  An update on the use of antifungal agents.

Authors:  Roberto Martinez
Journal:  J Bras Pneumol       Date:  2006 Sep-Oct       Impact factor: 2.624

5.  Successful medical therapy for deeply invasive facial infection due to Pythium insidiosum in a child.

Authors:  J L Shenep; B K English; L Kaufman; T A Pearson; J W Thompson; R A Kaufman; G Frisch; M G Rinaldi
Journal:  Clin Infect Dis       Date:  1998-12       Impact factor: 9.079

6.  A description of cutaneous-subcutaneous pythiosis in fifteen dogs.

Authors:  M J Dykstra; N J Sharp; T Olivry; A Hillier; K M Murphy; L Kaufman; G A Kunkle; C Pucheu-Haston
Journal:  Med Mycol       Date:  1999-12       Impact factor: 4.076

7.  Pythium insidiosum sp. nov., the etiologic agent of pythiosis.

Authors:  A W De Cock; L Mendoza; A A Padhye; L Ajello; L Kaufman
Journal:  J Clin Microbiol       Date:  1987-02       Impact factor: 5.948

8.  Human subcutaneous pythiosis.

Authors:  J A Triscott; D Weedon; E Cabana
Journal:  J Cutan Pathol       Date:  1993-06       Impact factor: 1.587

9.  In vitro sensitivity of Penicillium marneffei and Pythium insidiosum to various antifungal agents.

Authors:  A S Sekhon; A A Padhye; A K Garg
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

10.  Human pythiosis.

Authors:  Jakrapun Pupaibool; Ariya Chindamporn; Kanitha Patrakul; Chusana Suankratay; Wannasri Sindhuphak; Wanla Kulwichit
Journal:  Emerg Infect Dis       Date:  2006-03       Impact factor: 6.883
View more
  15 in total

1.  In Vitro activity of terbinafine combined with caspofungin and azoles against Pythium insidiosum.

Authors:  Ayrton S Cavalheiro; Grazieli Maboni; Maria I de Azevedo; Juliana S Argenta; Daniela I B Pereira; Tatiana B Spader; Sydney H Alves; Janio M Santurio
Journal:  Antimicrob Agents Chemother       Date:  2009-03-16       Impact factor: 5.191

2.  In vitro evaluation of the type of interaction obtained by the combination of terbinafine and itraconazole, voriconazole, or amphotericin B against dematiaceous molds.

Authors:  Fernanda Simas Corrêa Biancalana; Luzia Lyra; Angélica Zaninelli Schreiber
Journal:  Antimicrob Agents Chemother       Date:  2011-06-20       Impact factor: 5.191

3.  In vitro synergism observed with azithromycin, clarithromycin, minocycline, or tigecycline in association with antifungal agents against Pythium insidiosum.

Authors:  Francielli P K Jesus; Laerte Ferreiro; Érico S Loreto; Maiara B Pilotto; Aline Ludwig; Karine Bizzi; Juliana S M Tondolo; Régis A Zanette; Sydney H Alves; Janio M Santurio
Journal:  Antimicrob Agents Chemother       Date:  2014-07-07       Impact factor: 5.191

4.  New insights into the in vitro susceptibility of Pythium insidiosum.

Authors:  Erico S Loreto; Juliana S M Tondolo; Maiara B Pilotto; Sydney H Alves; Janio M Santurio
Journal:  Antimicrob Agents Chemother       Date:  2014-09-15       Impact factor: 5.191

5.  In vitro susceptibility of Pythium insidiosum to macrolides and tetracycline antibiotics.

Authors:  Erico Silva Loreto; Débora Alves Nunes Mario; Laura Bedin Denardi; Sydney Hartz Alves; Janio Morais Santurio
Journal:  Antimicrob Agents Chemother       Date:  2011-05-02       Impact factor: 5.191

6.  Evolution of the Sterol Biosynthetic Pathway of Pythium insidiosum and Related Oomycetes Contributes to Antifungal Drug Resistance.

Authors:  Tassanee Lerksuthirat; Areeporn Sangcakul; Tassanee Lohnoo; Wanta Yingyong; Thidarat Rujirawat; Theerapong Krajaejun
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

7.  In Vitro Susceptibility of Pythium insidiosum to Melaleuca alternifolia, Mentha piperita and Origanum vulgare Essential Oils Combinations.

Authors:  Júlia de Souza Silveira Valente; Anelise de Oliveira da Silva Fonseca; Laura Bedin Denardi; Vanessa Silveira Dal Ben; Fernando de Souza Maia Filho; Cristiane Telles Baptista; Caroline Quintana Braga; Cristina Gomes Zambrano; Sydney Hartz Alves; Sônia de Avila Botton; Daniela Isabel Brayer Pereira
Journal:  Mycopathologia       Date:  2016-05-21       Impact factor: 2.574

8.  Occidiofungin, a unique antifungal glycopeptide produced by a strain of Burkholderia contaminans.

Authors:  Shi-En Lu; Jan Novak; Frank W Austin; Ganyu Gu; Dayna Ellis; Marion Kirk; Shawanda Wilson-Stanford; Marco Tonelli; Leif Smith
Journal:  Biochemistry       Date:  2009-09-08       Impact factor: 3.162

9.  A case of relapsed chromoblastomycosis due to Fonsecaea monophora: antifungal susceptibility and phylogenetic analysis.

Authors:  Tatiane Caroline Daboit; Cibele Massotti Magagnin; Daiane Heidrich; Mauricio Ramírez Castrillón; Sandra Denise Camargo Mendes; Gerson Vettorato; Patrícia Valente; Maria Lúcia Scroferneker
Journal:  Mycopathologia       Date:  2013-05-04       Impact factor: 2.574

10.  In Vitro Synergism between Azithromycin or Terbinafine and Topical Antimicrobial Agents against Pythium insidiosum.

Authors:  Sabrina R Itaqui; Camila M Verdi; Juliana S M Tondolo; Thaisa S da Luz; Sydney H Alves; Janio M Santurio; Érico S Loreto
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.